Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Andtbacka, Robert H.I
86  Ergebnisse:
Personensuche X
?
1

Society for Immunotherapy of Cancer (SITC) recommendations ..:

Luke, Jason J ; Davar, Diwakar ; Andtbacka, Robert H...
Journal for ImmunoTherapy of Cancer.  12 (2024)  4 - p. e008378 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Ageing and endothelium‐mediated vascular dysfunction: the r..:

Kwon, Oh Sung ; Noh, Sung Gi ; Park, Soung Hun...
The Journal of Physiology.  601 (2022)  3 - p. 451-467 , 2022
Link: https://doi.org/10.1113/..
 
?
3

Intratumoral oncolytic virus V937 plus ipilimumab in patien..:

Curti, Brendan D ; Richards, Jon ; Hyngstrom, John R...
Journal for ImmunoTherapy of Cancer.  10 (2022)  12 - p. e005224 , 2022
Link: https://doi.org/10.1136/..
 
?
4

Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Incre..:

Andtbacka, Robert H.I. ; Wang, Yan ; Pierce, Robert H....
Cancer Research Communications.  2 (2022)  8 - p. 904-913 , 2022
Link: https://doi.org/10.1158/..
 
?
5

Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Incre..:

Andtbacka, Robert H.I ; Wang, Yan ; Pierce, Robert H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010370/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Supplementary Data from Phase I Dose-Escalation Trial of MI..:

Funda Meric-Bernstam ; Randy F. Sweis ; F. Stephen Hodi...
doi:10.1158/1078-0432.24932429.v1.  , 2022
Link: https://doi.org/10.1158/..
 
?
7

Figure S3 from Phase I Dose-Escalation Trial of MIW815 (ADU..:

Funda Meric-Bernstam ; Randy F. Sweis ; F. Stephen Hodi...
doi:10.1158/1078-0432.24932438.v1.  , 2022
Link: https://doi.org/10.1158/..
 
?
8

Figure S2 from Phase I Dose-Escalation Trial of MIW815 (ADU..:

Funda Meric-Bernstam ; Randy F. Sweis ; F. Stephen Hodi...
doi:10.1158/1078-0432.24932441.v1.  , 2022
Link: https://doi.org/10.1158/..
 
?
9

Figure S5 from Phase I Dose-Escalation Trial of MIW815 (ADU..:

Funda Meric-Bernstam ; Randy F. Sweis ; F. Stephen Hodi...
doi:10.1158/1078-0432.24932432.v1.  , 2022
Link: https://doi.org/10.1158/..
 
?
10

Intratumoral oncolytic virus V937 plus ipilimumab in patien..:

Gregory A Daniels ; Sigrun Hallmeyer ; Mark Grose...
https://jitc.bmj.com/content/10/12/e005224.full.  , 2022
Link: https://doi.org/10.1136/..
 
?
11

Intratumoral oncolytic virus V937 plus ipilimumab in patien..:

Curti, Brendan D ; Richards, Jon ; Hyngstrom, John R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791411/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Figure S1 from Phase I Dose-Escalation Trial of MIW815 (ADU..:

Funda Meric-Bernstam ; Randy F. Sweis ; F. Stephen Hodi...
doi:10.1158/1078-0432.24932444.v1.  , 2022
Link: https://doi.org/10.1158/..
 
?
13

Figure S4 from Phase I Dose-Escalation Trial of MIW815 (ADU..:

Funda Meric-Bernstam ; Randy F. Sweis ; F. Stephen Hodi...
doi:10.1158/1078-0432.24932435.v1.  , 2022
Link: https://doi.org/10.1158/..
 
?
14

A Phase IIb Randomized Controlled Trial of the TLPLDC Vacci..:

Vreeland, Timothy J. ; Clifton, Guy T. ; Hale, Diane F....
Annals of Surgical Oncology.  28 (2021)  11 - p. 6126-6137 , 2021
Link: https://doi.org/10.1245/..
 
?
15

BRAFV600E induces reversible mitotic arrest in human melano..:

McNeal, Andrew S ; Belote, Rachel L ; Zeng, Hanlin...
eLife.  10 (2021)  - p. , 2021
Link: https://doi.org/10.7554/..
 
1-15